Brief introduction：The first beta blocker which completed the Quality Consistency Evaluationpassed in China. Indicated to lower high blood pressure helps prevent strokes, heart attacks, and kidney problems.
Brief introduction：Deemed to have completed the Quality Consistency Evaluation; It's used for treatment of following: prevent Atherothrombosis; patients with acute myocardial infarction(AMI), ischemic stroke, peripheral arterial disease(PAD) and acute coronary syndrome(ACS).
Add: No.8, Xiyuan Ave., Hi-tech District, Chengdu, 611731, China
This website does not publish the product information of narcotic drugs, psychotropic drugs, toxic drugs for medical use, radioactive drugs, drug rehabilitation drugs and preparations of medical institutions.|
Copyright ? 成都苑东生物制药股份有限公司 ALL Rights Reserved互联网药品信息服务资格证编号：(川)-非经营性-2021-0036